Targets that are ‘difficult-to-drug’ typically have binding sites that are large, highly lipophilic or polar, flexible, flat or featureless [1]. They contain few opportunities for high affinity int...
No takes yet. Share an insight, caveat, or question.
Doak et al. (2016) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: